Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has awarded six regional companies $2.5 million in grants as part of its inaugural Ecosystem ...

Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary of global life sciences titan Bayer AG. Financial terms of the deal with ...

If you’re looking for an OTC medication that’ll ease pain and quell inflammation, there are several great options to choose ...

Fir Park midfielder returned to top team action after a year out this week - and is now looking forward to making up for lost ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

The "Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been ...

Rates of myalgic encephalomyelitis/chronic fatigue syndrome have dramatically increased since pre-pandemic times. A new large ...

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year from ...